Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 70.90
+0.40 (0.57%)
Jul 21, 2026, 1:53 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 4.8 billion as of July 21, 2026. Its market cap has increased by 241.31% in one year.
Market Cap
4.80B
Enterprise Value
4.37B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
70.90
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 4.80B, an increase of 114.17%. That is a compound annual growth rate of 38.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 4.80B | 19.80% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.00B |
| TWi Biotechnology | 5.50B |
| AnnJi Pharmaceutical | 5.34B |
| Mycenax Biotech | 5.08B |
| UnicoCell Biomed | 4.89B |
| Medigen Biotechnology | 4.71B |
| Pharmosa Biopharm | 4.52B |
| Sinew Pharma | 4.51B |